Atlas Trials

Invicro

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Invicro

RecordFirmDate
Open-label Study to Evaluate Brain α-Synuclein Deposition Using PET and [18F]MK-0947 in Parkinson's Disease (NCT07348250)Invicro2025-12-08
First-in-Human Study for the Safety and Evaluation of Two 4R Tau Ligands as Potential PET Radioligands for Imaging Tau Protein in the Brain (NCT07348276)Invicro2025-11-17
Proof of Mechanism Study to Evaluate Binding of Alfa-synuclein (NCT05274568)Invicro2022-01-31
Plasma P-tau2017 and Quantitative Amyloid PET Imaging (NCT05164536)Invicro2021-08-27
Occupancy of Adenosine A2A Receptors Using the PET Radiotracer [18F]MNI-444 (NCT05009199)Invicro2021-06-24
Evaluation of [18F]APN-1607 as a PET Biomarker (NCT05005819)Invicro2021-05-25
Study to Evaluate a Potential PET Radioligand for Imaging Alpha-synuclein Deposits in the Brain (NCT06445465)Invicro2020-12-24
D1 Receptor Occupancy (RO) Following a Single Dose of PF-06412562 (NCT03686501)Invicro2018-09-10
Assessment of [18F]MNI-1054 as a Marker for LSD1 (NCT03695926)Invicro2018-08-09
Evaluation of [18F]MNI-1126 as an Imaging Marker for Synaptic Density Loss (NCT03587649)Invicro2018-05-07
Phase 1 Test-retest Evaluation of [18F]MNI-958 PET (NCT03545789)Invicro2018-03-12
Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects (NCT03472313)Invicro2017-11-14

Track Invicro automatically

Every clearance here is in the API, with alerts when new ones post.